MétaCan
Menu
← Back to cohort
Record W4416140366 · doi:10.1093/neuonc/noaf201.1473

EXTH-142. Quantitative surfaceome profiling of high-risk medulloblastoma prioritizes the oncofetal antigen GPC2 for potent CAR-T cell therapy

2025· article· en· W4416140366 on OpenAlexaff
Diren Usta, William D. Gwynne, Yujin Suk, Yiyun Chen, Molly T Radosevic, Darya Chernova, Alberto Delaidelli, Emon Nasajpour, Maria Trissal, Rebecca Poetschke, Christopher Dunham, Louai Labanie, Jasper van der Lugt, Stefan Nierkens, Claudia Petritsch, Poul Sørensen, Katherine Ryan, Chitra Venugopal, Elena Sotillo, Crystal L. Mackall, Sheila K. Singh, Sabine Heitzeneder

Bibliographic record

VenueNeuro-Oncology · 2025
Typearticle
Languageen
FieldMedicine
TopicCAR-T cell therapy research
Canadian institutionsCanadian Centre for Applied Research in Cancer ControlBC Children's HospitalBC Cancer AgencyMcMaster University
Fundersnot available
KeywordsMedulloblastomaAntigenPotencyDiseaseTumor antigenImmunotherapyCell

Abstract

fetched live from OpenAlex

Abstract Recurrent medulloblastoma (MB) remains a devastating pediatric brain tumor with <10% survival. CAR-T cells have shown promise in aggressive childhood brain tumors, but success in MB is limited by suitable cell-surface targets. Requirements for efficacious CAR-T antigens include that levels in clinical specimens exceed CAR-T detection thresholds and absence in vital tissues. We profiled the CAR-T antigen landscape of MB using unbiased surfaceome analysis from tumor and normal tissue transcriptomes and precisely quantified antigen densities of selected candidates on tumor biopsies. We found that MB closely resembles prenatal brain and expresses several oncofetal proteins, ranking Glypican-2 (GPC2) as the top candidate. GPC2 antigen densities ranged from 0-15944 molecules/cell on GR3/GR4-MB subgroups (mean: 5019 +/-1595), which often exhibit diminished cure rates. Antigen density determines CAR-T potency and we previously engineered GPC2-CAR-Ts tuned towards clinical densities on neuroblastoma and demonstrated that cJUN-overexpression (OE) augments their potency by lowering antigen detection thresholds (Heitzeneder et. al, 2022). Here, we employ orthotopic xenograft models and locoregional CAR-T delivery to study the interplay between GPC2 antigen density and CAR potency and inform a phase-1 study design. We found that both GPC2-CAR-Ts (+/-cJUN) mediate durable disease control against GPC2-intermediate GR4-MB (ICB1299: 8979 mol/cell and MBT375, newly established PDX: 6270 mol/cell). In a highly aggressive, MYC-amplified, GPC2-high GR3-MB model (SU_MB002: 18493 mol/cell), recurrence was observed in 3/5 mice post GPC2-CAR, while repeated dosing or cJUN-OE significantly improved persistence and long-term anti-tumor control. In a GPC2-low, GR3-MB model (HDMB03: 2750 mol/cell) used to further dissect antigen detection limits, only cJUN.GPC2-CAR maintained anti-tumor responses. These data support an upcoming phase-1 clinical trial at Stanford, testing repeated, locoregional GPC2-CAR-T infusions in patients with recurrent/refractory MB and emphasize needing to enroll subjects with GPC2+ disease, that is predicted to be above CAR detection thresholds, aiming to provide targeted treatment options for this devastating malignancy.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.005

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.035
GPT teacher head0.358
Teacher spread0.323 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueNeuro-Oncology→Same topicCAR-T cell therapy research→French-language works237,207→